Nuvation Bio Inc. (NUVB) Institutional Ownership

Ownership Summary

Nuvation Bio Inc. (NYSE:NUVB) has 229 institutional investors that have filed 13F reports for the period ending March 2026.

• They owned 63474.2% of outstanding stock in March 2026, down from 63906.4% the prior quarter.
• Their total shares held in NUVB increased 12.68% from the prior quarter, while the number of investors in Nuvation Bio increased 41.36% year over year.
• Among the 229 funds, 137 bought more Nuvation Bio shares, 58 sold down, and 34 held their ground.
• Institutional investors collectively held 220.47Mn shares in Nuvation Bio as of March 2026, up by 24.8Mn shares quarter on quarter, and up 6.76Mn shares year over year.
• As of March 31, 2026, FMR LLC held the largest stake in Nuvation Bio with 51.99Mn shares, accounting for 14968.27% of total shares outstanding.
• Top purchasers of NUVB stock for the quarter ending March 2026 included VANGUARD CAPITAL MANAGEMENT LLC (11.63Mn), Duquesne Family Office LLC (4.54Mn), AMERICAN CENTURY COMPANIES INC (2.86Mn), Jones Hill Capital LP (2.38Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.28Mn).
• The biggest sellers of Nuvation Bio for the quarter ending March 2026 included Laurion Capital Management LP (7.88Mn), ABRAMS CAPITAL MANAGEMENT, L.P. (2.54Mn), Nuveen, LLC (2.34Mn), Goldman Sachs Group Inc (1.46Mn), MARSHALL WACE, LLP (1.13Mn).
• Per Business Quant, the top 10 investors in NUVB for the quarter ending March 2026 include FMR LLC (51.99Mn), Decheng Capital LLC (25.95Mn), BlackRock, Inc. (25.1Mn), VANGUARD CAPITAL MANAGEMENT LLC (11.63Mn), Omega Fund Management, LLC (8.08Mn), Laurion Capital Management LP (7.82Mn), State Street Corp (6.78Mn), GEODE CAPITAL MANAGEMENT, LLC (5.86Mn), Duquesne Family Office LLC (4.54Mn), Bank Of America Corp /De/ (3.22Mn).